PDCD1 and psoriasis: To date, some of the pathogenic mechanisms underlying immune-related psoriasis reactions in patients treated with anti-PD-1 have been described, even though the specific patterns of innate and adaptive immunity prevailing in the skin lesions are still to be elucidated.